Congress Demands Answers on Data Privacy Ahead of 23andMe Sale
House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer genetic data under a change of ownership.
‘Uber for Getting Off Antidepressants’ Launches in the US
Outro, which is now available in seven states, wants to help people taper off antidepressants without experiencing debilitating side effects.
Uber Just Reinvented the Bus … Again
Beyond the jokes about its new shuttle service are serious questions about what it will mean for struggling transit systems, air quality, and congestion.
Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug
As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 medication injected daily instead of weekly.
The Future of Manufacturing Might Be in Space
Products made in space—and used on Earth—could be a reality in the coming years.
The Dream of the Metaverse Is Dying. Manufacturing Is Keeping It Alive
Forget Mark Zuckerberg’s vision of VR meetings; the industrial metaverse bridges digital and physical worlds in a way that’s actually useful.
The Climate Crisis Threatens Supply Chains. Manufacturers Hope AI Can Help
The Covid-19 pandemic showed just how vulnerable global supply chains are. Climate shocks could pose an even greater risk.
2025 Is the Year of the Humanoid Robot Factory Worker
Long confined to the lab, humanoids finally appear ready to work in manufacturing. There are just a few hurdles to get them to market.
The Agonizing Task of Turning Europe’s Power Back On
A massive blackout affecting Spain, Portugal, and parts of France has been blamed on atmospheric conditions. Now engineers face the arduous task of getting the power back on.
Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs
Pharmaceutical giant Eli Lilly alleges the companies are selling off-brand versions of its best-selling diabetes and weight-loss drugs, Mounjaro and Zepbound.